In an older adult with anxiety, should hydroxyzine be discontinued due to age‑related sedation, anticholinergic effects, and fall risk?

Hydroxyzine in Older Adults with Anxiety: Age is a Critical Factor

Yes, patient age is absolutely a critical factor—hydroxyzine should generally be avoided or discontinued in older adults due to significant anticholinergic effects, sedation, fall risk, and cognitive impairment, even when treating anxiety. While hydroxyzine may have demonstrated efficacy for generalized anxiety disorder in some studies, the risks in older adults typically outweigh benefits 1, 2, 3.

Why Age Matters: The Evidence Against Hydroxyzine in Older Adults

Guideline-Based Contraindications

• The 2015 American Geriatrics Society explicitly recommends avoiding hydroxyzine in older adults due to its potent anticholinergic properties, which increase risk of delirium, cognitive impairment, and falls 2.

• The FDA drug label specifically warns that elderly patients are more sensitive to psychomotor impairment from hydroxyzine and should be started on low doses with close observation due to increased risk of confusion and oversedation 3.

• The 2008 rhinitis guidelines emphasize that older adults are more sensitive to psychomotor impairment from first-generation antihistamines like hydroxyzine, face increased fall risk with complications including fractures and subdural hematomas, and are more susceptible to adverse anticholinergic effects 1.

Specific Risks in Older Adults

Anticholinergic burden: Hydroxyzine contributes significantly to cumulative anticholinergic exposure, which is associated with:

• Cognitive decline and delirium 4, 2, 5
• Increased fall risk, even with cumulative exposure to multiple drugs with mild anticholinergic properties 6, 5
• Dry mouth, constipation, urinary retention, and narrow-angle glaucoma provocation 1, 3

Sedation and performance impairment:

• Hydroxyzine causes impaired driving performance that worsens with activities like cell phone use 1
• Sedation may persist into the next day despite dosing at bedtime, with performance impairment occurring without subjective awareness of drowsiness 1
• The FDA label notes sedating drugs may cause confusion and oversedation specifically in the elderly 3

Cardiovascular concerns:

• QT prolongation and Torsade de Pointes have been reported, particularly concerning in older adults with pre-existing heart disease, electrolyte imbalances, or concomitant arrhythmogenic drug use 3

When Hydroxyzine Might Be Considered (Rarely)

The evidence does show hydroxyzine can be effective for anxiety:

• A Cochrane review found hydroxyzine more effective than placebo for GAD (OR 0.30,95% CI 0.15 to 0.58), though the review noted high risk of bias in included studies 7
• One study in elderly subjects found hydroxyzine 25 mg preserved memory and attention better than lorazepam 1 mg, though some minimal sedation was noted 8

However, these potential benefits do not outweigh the substantial risks in most older adults 1, 2.

Safer Alternatives for Anxiety in Older Adults

Preferred pharmacological options include:

• Second-generation antihistamines (if antihistamine properties are desired) such as fexofenadine, loratadine, or desloratadine, which do not cause sedation at recommended doses 1
• Low-dose SSRIs or SNRIs for generalized anxiety disorder
• Short-term, low-dose benzodiazepines (e.g., lorazepam 0.25-0.5 mg) only when absolutely necessary, recognizing these also carry fall and cognitive risks 9

For acute anxiety or agitation in specific contexts (e.g., palliative care, severe distress):

• Lorazepam 0.5-1 mg orally (reduced to 0.25-0.5 mg in elderly/debilitated patients) 9
• Haloperidol 0.5-1 mg (reduced to 0.25-0.5 mg in older/frail patients) for delirium with anxiety 10, 9

Clinical Decision Algorithm

When encountering hydroxyzine in an older adult:

1. Assess the indication: Is it truly for anxiety, or is it being used for sleep, pruritus, or another indication?

2. Evaluate risk factors: Does the patient have cognitive impairment, fall history, cardiac disease, polypharmacy, or other anticholinergic medications? 3, 6

3. Consider deprescribing: In most cases, hydroxyzine should be tapered and discontinued, with transition to safer alternatives 11, 5

4. If continuation is considered: Use the lowest possible dose (starting at 10-25 mg), monitor closely for sedation, confusion, falls, and anticholinergic effects, and reassess frequently 12, 3

Common Pitfalls

• Assuming "as needed" dosing is safer: Even intermittent use carries risks in older adults due to prolonged half-lives and end-organ effects that persist longer than plasma levels 1
• Combining with other sedating or anticholinergic medications: This dramatically increases risk, yet is common in practice with polypharmacy 4, 6
• Prescribing for sleep without considering safer alternatives: Hydroxyzine shows mixed efficacy for insomnia and should only be considered short-term when other options have failed 13

The bottom line: While hydroxyzine may occasionally be appropriate for anxiety in younger adults, age-related physiological changes and increased vulnerability to adverse effects make it generally inappropriate for older adults, warranting discontinuation in most cases 1, 2, 3.